Evidence map›Paper›PMID 30415354›Full record

Trial reportObesity surgery2019

Impact of Bariatric Surgery on the Pharmacokinetics Parameters of Amoxicillin.

Marina Becker Sales Rocha, Gilberto De Nucci, Francisco Ney Lemos, Rodrigo Feitosa de Albuquerque Lima Babadopulos, Andrea Vieira Pontes Rohleder, Francisco Vagnaldo Fechine, Natalícia J Antunes, Gustavo D Mendes, Demetrius Fernandes do Nascimento, Manoel Odorico de Moraes and 1 more

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Obesity surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03588273 (Impact of Bariatric Surgery on the Pharmacokinetics Parameters of Amoxicillin), which is not on this map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03588273 nacompletednot on this map

Impact of Bariatric Surgery on the Pharmacokinetics Parameters of Amoxicillin

TypeinterventionalSponsorNucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do CearaRan2016 to 2017Enrolled8ConditionsBariatric Surgery CandidateArmsAmoxil 500 MG Oral Capsule
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2019
    Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Marina Becker Sales RochaClinical Pharmacology Unit, Drug Research and Development Center, Federal University of Ceara (UFC), Rua Cel. Nunes de Melo 1000 - Rodolfo Teófilo, Fortaleza, Ceará, 60430-275, Brazil. marinabecker@hotmail.com.br.ORCID http://orcid.org/0000-0001-7197-4599
Gilberto De NucciFaculty of Medical Sciences, Department of Pharmacology, State University of Campinas, Campinas, São Paulo, Brazil.
Francisco Ney LemosUnit of Bariatric Surgery, Hospital General Dr. César Cals, Avenida Imperador, 545, centro, Fortaleza, 60015-152, CE, Brazil.
Rodrigo Feitosa de Albuquerque Lima BabadopulosUnit of Bariatric Surgery, Hospital General Dr. César Cals, Avenida Imperador, 545, centro, Fortaleza, 60015-152, CE, Brazil.
Andrea Vieira Pontes RohlederClinical Pharmacology Unit, Drug Research and Development Center, Federal University of Ceara (UFC), Rua Cel. Nunes de Melo 1000 - Rodolfo Teófilo, Fortaleza, Ceará, 60430-275, Brazil.
Francisco Vagnaldo FechineClinical Pharmacology Unit, Drug Research and Development Center, Federal University of Ceara (UFC), Rua Cel. Nunes de Melo 1000 - Rodolfo Teófilo, Fortaleza, Ceará, 60430-275, Brazil.
Natalícia J AntunesFaculty of Medical Sciences, Department of Pharmacology, State University of Campinas, Campinas, São Paulo, Brazil.
Gustavo D MendesDepartment of Pharmacology, Metropolitan University of Santos, Santos, Brazil.
Demetrius Fernandes do NascimentoClinical Pharmacology Unit, Drug Research and Development Center, Federal University of Ceara (UFC), Rua Cel. Nunes de Melo 1000 - Rodolfo Teófilo, Fortaleza, Ceará, 60430-275, Brazil.
Manoel Odorico de MoraesClinical Pharmacology Unit, Drug Research and Development Center, Federal University of Ceara (UFC), Rua Cel. Nunes de Melo 1000 - Rodolfo Teófilo, Fortaleza, Ceará, 60430-275, Brazil.
Maria Elisabete Amaral de MoraesClinical Pharmacology Unit, Drug Research and Development Center, Federal University of Ceara (UFC), Rua Cel. Nunes de Melo 1000 - Rodolfo Teófilo, Fortaleza, Ceará, 60430-275, Brazil.
Universidade Federal do Ceará · BRHospital Geral de Fortaleza · BRUniversidade Estadual de Campinas (UNICAMP) · BRFaculdade São Leopoldo Mandic · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBariatric surgery leads to several anatomo-physiological modifications that may affect pharmacokinetic parameters and consequently alter the therapeutic effect of drugs, such as antibiotics. The pharmacokinetics of oral amoxicillin after Roux-en-Y gastric bypass (RYGB) surgery is unknown.

objectivesThe objective of this study was to evaluate the impact of bariatric surgery on the pharmacokinetics of amoxicillin.

methodsThis study was performed as a randomized, open-label, single-dose clinical trial, with two periods of treatment, in which obese subjects (n = 8) received an amoxicillin 500 mg capsule orally before and 2 months after the RYGB surgery. The amoxicillin plasma concentration was determined by liquid chromatography coupled to mass spectrometry (LC-MS/MS).

resultsAfter the surgery, the mean weight loss was 17.03 ± 5.51 kg, and mean body mass index (BMI) decreased from 46.21 ± 2.82 to 38.82 ± 3.32 kg/m

conclusionThe alterations observed in the amoxicillin pharmacokinetics suggest that obese subjects included in this trial had a substantially increase in amoxicillin systemic exposure after RYGB surgery. However, despite this increase, its exposure was lower than the values reported for non-obese volunteers.

trial registrationIdentifiers: NCT03588273.

Indexed as

Gastric BypassAdministration, OralAdultAmoxicillinAnti-Bacterial AgentsBody Mass IndexChromatography, LiquidFemaleHumansMaleMiddle AgedObesity, MorbidTandem Mass SpectrometryWeight LossAmoxicillinAnti-Bacterial AgentsAmoxicillinBariatric surgeryGastric bypassObesityPharmacokinetics

Identifiers

PMID30415354
OpenAlexW2899802920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.